# Boston Scientific Corp: PMA supplement approved for WATCHMAN FLX™ Left Atrial Appendage Closure Device with Delivery System; WATCHMAN FLX™ Pro

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Boston Scientific Corp |
| Product | WATCHMAN FLX™ Left Atrial Appendage Closure Device with Delivery System; WATCHMAN FLX™ Pro Left Atrial Appendage Closure |
| Generic / ingredient | System, appendage closure, left atrial |
| Approval | PMA supplement (device change) |
| Application | P130013 S086 |
| Decided | 2026-07-21 |
| Panel / class | Cardiovascular |
| Sponsor location | Maple Grove, MN |

## Why this score


Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130013S086). Last refreshed: 2026-11-04T06:06:18.796Z.
From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.